valaciclovir sandoz 500 mg
sandoz a/s - valaciklovirhydroklorid - tablett, filmdrasjert - 500 mg
valaciclovir sandoz 250 mg
sandoz a/s - valaciklovirhydroklorid - tablett, filmdrasjert - 250 mg
aciclovir pfizer 25 mg/ ml
pfizer as - aciklovirnatrium - konsentrat til infusjonsvæske, oppløsning - 25 mg/ ml
aciclovir accord 25 mg/ ml
accord healthcare b.v. - aciklovirnatrium - konsentrat til infusjonsvæske, oppløsning - 25 mg/ ml
verzenios
eli lilly nederland b.v. - abemaciclib - bryst neoplasms - antineoplastiske midler - early breast cancerverzenios in combination with endocrine therapy is indicated for the adjuvant treatment of adult patients with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative, node positive early breast cancer at high risk of recurrence (see section 5. in pre or perimenopausal women, aromatase inhibitor endocrine therapy should be combined with a luteinising hormone-releasing hormone (lhrh) agonist. advanced or metastatic breast cancerverzenios is indicated for the treatment of women with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative locally advanced or metastatic breast cancer in combination with an aromatase inhibitor or fulvestrant as initial endocrine-based therapy, or in women who have received prior endocrine therapy. in pre- or perimenopausal women, the endocrine therapy should be combined with a lhrh agonist.
provocholine 100 mg
acic europe limited - metakolinklorid - pulver til inhalasjonsvæske til nebulisator, oppløsning - 100 mg
rimstar
2care4 aps - rifampicin / isoniazid / pyrazinamid / etambutolhydroklorid - tablett, filmdrasjert - 150 mg / 75 mg / 400 mg / 275 mg
zovirax 800 mg
glaxosmithkline as - aciklovir - tablett - 800 mg
zovirax 80 mg/ ml
glaxosmithkline as - aciklovir - mikstur, suspensjon - 80 mg/ ml